&#
x3b2;-Amyloid (A&#
x3b2;) aggregation is the major pathological feature of Alzheimer's disease (AD), resulting in oxidative stress and further exacerbating A&#
x3b2; aggregation. Ginger leaf polyphenols (GLP) have been found to possess antioxidant activity, evidencing their potential in addressing AD. GLP is mainly composed of 12 polyphenols, 8 organic acids, and 6 glycosides, of which polyphenols are predominantly composed of apigenin, kaempferol, and quercetin derivatives. Moreover, GLP alleviates reproductive toxicity, longevity toxicity, and neurotoxicity induced by A&#
x3b2; <i>via</i> regulating the antioxidase system in <i>Caenorhabditis elegans</i>. As shown by the network pharmacology results, GLP might activate the JNK/Foxo signaling pathway to regulate the antioxidase system, which was evidenced by the up-regulation of gene expression levels of <i>
jnk-1</i>, <i>
daf-16</i>, <i>
sod-3</i>, and <i>
hsp-16.2</i>. Overall, GLP might be a potential antioxidant for combating AD.